CARBIDOPA-LEVODOPA 25-250 TAB
For 30 tablets
Pharmacies pay
$3.57 filed
30 × $0.11894 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$4.14 filed
30 × $0.138 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.2× estimated
Medicare paid 1.2× what pharmacies pay.
Part D averages every strength and form sold under “Carbidopa-Levodopa” / “Carbidopa/Levodopa” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$9.11 estimated
$3.57 + $0.54 (15%) + $5.00 fee per fill = $9.11
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CARBIDOPA-LEVODOPA 25-250 TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as carbidopa and levodopa, under the trade name “Carbidopa-levodopa”.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Aromatic Amino Acid.
The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 22 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.57 for 30 tablets (30 × $0.11894 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Advagen Pharma Ltd., | 3 | $0.11894 per EA filed |
| Camber Pharmaceuticals, Inc. | 3 | $0.11894 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 3 | $0.11894 per EA filed |
| TruPharma, LLC | 3 | $0.11894 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.11894 per EA filed |
| Dr. Reddy's Laboratories Inc | 2 | $0.11894 per EA filed |
| ScieGen Pharmaceuticals Inc | 2 | $0.11894 per EA filed |
| Westminster Pharmaceuticals, LLC | 2 | $0.11894 per EA filed |
| American Health Packaging | 1 | $0.11894 per EA filed |
| Major Pharmaceuticals | 1 | $0.11894 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.11894 per EA filed |
All 23 NDCs, with labeler and price
- 00093-9703-01 · Teva Pharmaceuticals USA, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 00093-9703-05 · Teva Pharmaceuticals USA, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 00093-9703-10 · Teva Pharmaceuticals USA, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 00904-7549-61 · Major Pharmaceuticals · $0.11894 per EA · eff. 2026-09-23 filed
- 31722-0383-01 · Camber Pharmaceuticals, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 31722-0383-05 · Camber Pharmaceuticals, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 31722-0383-10 · Camber Pharmaceuticals, Inc. · $0.11894 per EA · eff. 2026-09-23 filed
- 50228-0459-01 · ScieGen Pharmaceuticals Inc · $0.11894 per EA · eff. 2026-09-23 filed
- 50228-0459-05 · ScieGen Pharmaceuticals Inc · $0.11894 per EA · eff. 2026-09-23 filed
- 52817-0392-00 · TruPharma, LLC · $0.11894 per EA · eff. 2026-09-23 filed
- 52817-0392-10 · TruPharma, LLC · $0.11894 per EA · eff. 2026-09-23 filed
- 52817-0392-50 · TruPharma, LLC · $0.11894 per EA · eff. 2026-09-23 filed
- 59651-0458-01 · Aurobindo Pharma Limited · $0.11894 per EA · eff. 2026-09-23 filed
- 59651-0458-05 · Aurobindo Pharma Limited · $0.11894 per EA · eff. 2026-09-23 filed
- 60687-0836-01 · American Health Packaging · $0.11894 per EA · eff. 2026-09-23 filed
- 60687-0836-11 · not listed as a package in the FDA directory · $0.11894 per EA · eff. 2026-09-23 filed
- 69367-0340-01 · Westminster Pharmaceuticals, LLC · $0.11894 per EA · eff. 2026-09-23 filed
- 69367-0340-05 · Westminster Pharmaceuticals, LLC · $0.11894 per EA · eff. 2026-09-23 filed
- 72888-0108-00 · Advagen Pharma Ltd., · $0.11894 per EA · eff. 2026-09-23 filed
- 72888-0108-01 · Advagen Pharma Ltd., · $0.11894 per EA · eff. 2026-09-23 filed
- 72888-0108-05 · Advagen Pharma Ltd., · $0.11894 per EA · eff. 2026-09-23 filed
- 75907-0021-01 · Dr. Reddy's Laboratories Inc · $0.11894 per EA · eff. 2026-09-23 filed
- 75907-0021-05 · Dr. Reddy's Laboratories Inc · $0.11894 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
18 other products in the NADAC file share the FDA nonproprietary name carbidopa and levodopa with CARBIDOPA-LEVODOPA 25-250 TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CARBIDOPA-LEVO 25-100 MG ODT | $0.68655 per EA filed | We don’t know yet |
| CARBIDOPA-LEVO ER 23.75-95 CAP | $3.15323 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVO ER 25-100 TAB | $0.11014 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVO ER 36.25-145 CP | $3.3941 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVO ER 48.75-195 CP | $3.18794 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVO ER 50-200 TAB | $0.17959 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVO ER 61.25-245 CP | $3.92786 per EA filed | $0.35658 per EA filed |
| CARBIDOPA-LEVODOPA 10-100 TAB | $0.06826 per EA filed | $0.138 per EA filed |
| CARBIDOPA-LEVODOPA 25-100 TAB | $0.07589 per EA filed | $0.138 per EA filed |
| CARBIDOPA-LEVODOPA 25-250 TAB this page | $0.11894 per EA filed | $0.138 per EA filed |
| CREXONT ER 35 MG-140 MG CAP | $4.58989 per EA filed | We don’t know yet |
| CREXONT ER 52.5 MG-210 MG CAP | $4.5824 per EA filed | We don’t know yet |
| CREXONT ER 70 MG-280 MG CAP | $4.58002 per EA filed | We don’t know yet |
| CREXONT ER 87.5 MG-350 MG CAP | $4.58252 per EA filed | We don’t know yet |
| RYTARY ER 23.75 MG-95 MG CAP | $3.98069 per EA filed | We don’t know yet |
| RYTARY ER 36.25 MG-145 MG CAP | $3.9763 per EA filed | We don’t know yet |
| RYTARY ER 48.75 MG-195 MG CAP | $3.98378 per EA filed | We don’t know yet |
| RYTARY ER 61.25 MG-245 MG CAP | $4.99716 per EA filed | We don’t know yet |
| SINEMET 25-100 MG TABLET | $1.42358 per EA filed | $1.28606 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 23 NDCs’ NADAC prices is $0.11894 per EA filed.
Of the 25 other products in FDA’s Aromatic Amino Acid class priced per EA, 22 have a higher middle NADAC price and 3 a lower one. The one in the middle is CARBIDOPA-LEVO ER 23.75-95 CAP, at $3.15323 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $4.14 for 30 tablets, at an average of $0.138 per EA in 2024 (2024-01-01 to 2024-12-31) for “Carbidopa-Levodopa” and “Carbidopa/Levodopa”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 2,964,396 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CARBIDOPA-LEVODOPA 25-250 TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Carbidopa-Levodopa / Carbidopa/Levodopa: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.